openPR Logo

Press Releases from Greystone Research Associates (106 total)

Therapeutic Proteins to Reach $103 Billion by 2014, According to Greystone Resea …

(Amherst, NH) – Driven primarily by strong demand for engineered antibodies for treating a growing list of cancers, commercial protein drugs - a group that includes recombinant mAbs, cytokines and related immune modulators, growth factors, enzymes, and hormones - are forecast to grow at a 9.7% CAGR over the next four years, reaching $103 billion by 2014, according to the latest estimates from Greystone Research Associates. “Growth in this sector will

Synthetic Endovascular Repair Systems to Top $2 Billion by 2013, Says Greystone …

(Amherst, NH) – The global market for synthetic endovascular repair (SER) systems will grow at an average annual rate of seventeen percent over the next four years and will exceed $ 2 billion in 2013, according to the latest estimates from Greystone Research Associates. While abdominal aortic aneurysms account for about 90 percent of all procedures, repair of thoracic aortic aneurysms (TAA) is the fastest growing application segment for SER.

Specialty Injectable Drugs to Top $90 Billion by 2014, According to Greystone Re …

(Amherst, NH) – Driven by greater patient acceptance and evolving formulation and administration options, the global value of specialty injectable drugs in key market segments will grow to more than $90 billion over the next four years, according to the latest estimates from Greystone Research Associates. This forecast is based on an analysis of the eight largest specialty injectable therapeutic segments that also examined the relationship between product dosage forms

Therapeutic Microneedles to Exceed $400 Million in 2013, Says Greystone Research

(Amherst, NH) – Driven by the promise of derivative products that combine microneedles with existing drug delivery platforms, microneedle drug delivery will grow at a rate of 60 percent annually over the next four years, according to the latest estimates from Greystone Research Associates. Much of the growth will come from microneedle products for the delivery of vaccines and will be led by delivery systems that incorporate existing technology.

Wireless Hospital Monitors to Exceed $600 Million in 2013, According to Greyston …

(Amherst, NH) – Wirelessly enabled in-hospital patient monitors are expected to grow at an annual rate of 13 percent over the next four years according to the latest estimates from Greystone Research Associates. The majority of growth over the period will come from the addition of wireless units at hospitals that currently own wireless monitors. “The benefits of wireless bedside and in-patient ambulatory monitors will prompt many current facilities to include

Dominance of Patient Self-Administration in Key Disease Segments Increasing, Fin …

(Amherst, NH) – The global value of non-oral drug self-administration will exceed $130 billion in 2014, according to the latest estimates from Greystone Research Associates. This forecast is based on the analysis of more than two dozen therapeutic segments that also found the number of non-oral pipeline candidates increasing after a temporary decline. According to Greystone Research Associates Managing Director George Perros, “As the dynamics of patient populations and disease prevalence

Go To Page:    1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 -17 -16 -15 -14 -13 -12 -11 -10 -9 -8 -7 -6 -5 -4 -3 -2 -1 0